A recombinant multi-epitope protein MEP1 elicits efficient long-term immune responses against HIV-1 infection
The effective protective HIV vaccine should elicit either protective antibodies or effective T cell response, or both. To improve the efficacy of HIV-1 vaccines, HLA polymorphism and HIV-1 diversity are 2 key factors to be considered for vaccine development. In this study, we expressed a recombinant...
Main Authors: | Yi Yang, Qing Zhu, Weilai Sun, Jingjing Guo, Xiuzhe Ning, Qiao Li, Yan Guo, Junfeng Li, Zhihua Kou, Yusen Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-06-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2017.1281488 |
Similar Items
-
Immunoinformatics Approach to T-cell Epitopes in Human Immunodeficiency Virus
by: Deepa Chaturvedi, et al.
Published: (2013-12-01) -
A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against <i>Leishmania infantum</i> Infection
by: Daniela P. Lage, et al.
Published: (2022-07-01) -
Production and Immunogenicity Assessment of LTp50: An <i>Escherichia coli</i>-Made Chimeric Antigen Targeting S1- and S2-Epitopes from the SARS-CoV-2/BA.5 Spike Protein
by: Alejandra Wong-Arce, et al.
Published: (2024-02-01) -
Antigen epitopes of animal coronaviruses: a mini-review
by: Mingjun Su, et al.
Published: (2023-05-01) -
Application of built-in adjuvants for epitope-based vaccines
by: Yao Lei, et al.
Published: (2019-01-01)